Wedmont Private Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Wedmont Private Capital's PFE Position: Q2 2026 in Review
Wedmont Private Capital reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $260K and leaving 41,785 shares worth $1.01M. The position accounts for 0.03% of the portfolio, ranked #349.
Wedmont Private Capital first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.88M in Q4 2022. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wedmont Private Capital held 41,785 shares of Pfizer worth $1.01M as of Q2 2026.
- Wedmont Private Capital sold 9,950 Pfizer shares in Q2 2026, an estimated $260K.
- Pfizer made up 0.03% of Wedmont Private Capital's portfolio in Q2 2026, its #349 holding.
- Wedmont Private Capital first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Wedmont Private Capital's Pfizer position peaked at $1.88M in Q4 2022.
- 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.